Zenith Capital Corporation (TSXV:ZENI.P) announced a private placement of 3,333,334 common shares at an issue price of $1.5 per share for gross proceeds of $5,000,001 on June 16, 2020. The transaction will involve participation from an affiliate of Newsoara Biopharma Co., Ltd. The company will receive funding in tranches. The company is expected to close the transaction on or before August 31, 2020. On June 16, 2020, Zenith Capital Corporation (TSXV:ZENI.P) closed the transaction. The company issued 1,333,334 common shares for gross proceeds of $2,000,001 in the transaction.